MediciNova, Inc. (MNOV)

MediciNova Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	-	1	-	4.04	-
Gross Profit	-	1	-	4.04	-
Selling, General & Admin	5.48	5.24	5.48	5.72	6.69
Research & Development	7.19	5.66	9.14	8.54	7.48
Operating Expenses	12.68	10.9	14.63	14.25	14.18
Operating Income	-12.68	-9.9	-14.63	-10.22	-14.18
Interest & Investment Income	1.67	1.83	0.81	0.14	0.36
Other Non Operating Income (Expenses)	-0.04	-0.5	-0.25	-0.06	-0.04
Pretax Income	-11.04	-8.57	-14.07	-10.13	-13.86
Income Tax Expense	0.01	0	0	0	-0
Net Income	-11.05	-8.57	-14.07	-10.13	-13.85
Net Income to Common	-11.05	-8.57	-14.07	-10.13	-13.85
Shares Outstanding (Basic)	49	49	49	49	44
Shares Outstanding (Diluted)	49	49	49	49	44
Shares Change (YoY)	-	0.00%	0.92%	9.42%	2.91%
EPS (Basic)	-0.23	-0.17	-0.29	-0.21	-0.31
EPS (Diluted)	-0.23	-0.17	-0.29	-0.21	-0.31
Free Cash Flow	-10.64	-7.45	-12.92	-9.41	-10.86
Free Cash Flow Per Share	-0.22	-0.15	-0.26	-0.19	-0.24
Gross Margin	-	100.00%	-	100.00%	-
Operating Margin	-	-990.03%	-	-253.02%	-
Profit Margin	-	-857.15%	-	-251.00%	-
Free Cash Flow Margin	-	-745.23%	-	-233.07%	-
EBITDA	-12.65	-9.88	-14.61	-10.19	-14.16
EBITDA Margin	-	-	-	-252.38%	-
D&A For EBITDA	0.02	0.02	0.02	0.03	0.02
EBIT	-12.68	-9.9	-14.63	-10.22	-14.18
EBIT Margin	-	-	-	-253.02%	-

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q